Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Ocugen Inc (OCGN)

Ocugen Inc (OCGN)
0.7380 +0.0210 (+2.93%) 15:50 ET [NASDAQ]
0.7274 x 100 0.7348 x 100
Realtime by (Cboe BZX)
0.7274 x 100 0.7348 x 100
Realtime 0.7229 +0.0059 (-) 09:27 ET
Quote Overview for Thu, Apr 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.7100
Day High
0.7400
Open 0.7152
Previous Close 0.7170 0.7170
Volume 1,767,129 1,767,129
Avg Vol 3,907,460 3,907,460
Stochastic %K 81.06% 81.06%
Weighted Alpha -47.64 -47.64
5-Day Change +0.0816 (+12.49%) +0.0816 (+12.49%)
52-Week Range 0.5150 - 2.0600 0.5150 - 2.0600
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 209,374
  • Shares Outstanding, K 292,014
  • Annual Sales, $ 4,060 K
  • Annual Income, $ -54,050 K
  • EBIT $ -55 M
  • EBITDA $ -53 M
  • 60-Month Beta 3.78
  • Price/Sales 49.51
  • Price/Cash Flow N/A
  • Price/Book 6.76
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.19
  • Most Recent Earnings $-0.05 on 03/05/25
  • Next Earnings Date 05/13/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 240.81% ( -35.14%)
  • Historical Volatility 109.09%
  • IV Percentile 98%
  • IV Rank 56.56%
  • IV High 366.87% on 04/22/25
  • IV Low 76.66% on 08/08/24
  • Put/Call Vol Ratio 0.18
  • Today's Volume 751
  • Volume Avg (30-Day) 615
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 25,404
  • Open Int (30-Day) 34,112

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.06
  • Number of Estimates 2
  • High Estimate -0.05
  • Low Estimate -0.07
  • Prior Year -0.05
  • Growth Rate Est. (year over year) -20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5700 +28.91%
on 04/09/25
Period Open: 0.6374
0.8000 -8.15%
on 03/28/25
+0.0974 (+15.28%)
since 03/24/25
3-Month
0.5150 +42.68%
on 03/19/25
Period Open: 0.7800
0.8000 -8.15%
on 03/28/25
-0.0452 (-5.79%)
since 01/24/25
52-Week
0.5150 +42.68%
on 03/19/25
Period Open: 1.1800
2.0600 -64.33%
on 05/16/24
-0.4452 (-37.73%)
since 04/24/24

Most Recent Stories

More News
Ocugen to Present at the 2025 Cell & Gene Meeting on the Med

OCGN : 0.7380 (+2.93%)
Data and Safety Monitoring Board Reviews Cohort 1 Safety Data and Approves Dosing Cohort 2 in the Clinical Trial of OCU200—a Novel Fusion Protein for Diabetic Macular Edema

OCGN : 0.7380 (+2.93%)
Ocugen Stock Lifts Retail Investor Confidence As Q4 Revenue Crushes Estimates

Watchers on Stocktwits expressed optimism about the company’s pipeline and its aim to secure three BLAs over the next three years.

VHT : 250.68 (+1.54%)
VTI : 268.99 (+2.11%)
IWM : 194.12 (+2.03%)
OCGN : 0.7380 (+2.93%)
Ocugen (OCGN) Q4 2024 Earnings Call Transcript

OCGN earnings call for the period ending December 31, 2024.

OCGN : 0.7380 (+2.93%)
Ocugen: Q4 Earnings Snapshot

Ocugen: Q4 Earnings Snapshot

OCGN : 0.7380 (+2.93%)
Ocugen Provides Business Update with Fourth Quarter and Full Year 2024 Financial Results

OCGN : 0.7380 (+2.93%)
Ocugen Announces Positive Opinion of EMA’s Committee for Advanced Therapies for ATMP Classification for Novel Modifier Gene Therapy Candidate OCU410 for Geographic Atrophy and OCU410ST for Stargardt Disease

OCGN : 0.7380 (+2.93%)
Ocugen, Inc. Announces FDA Alignment on Phase 2/3 Pivotal Confirmatory Clinical Trial for Modifier Gene Therapy Candidate OCU410ST for Stargardt Disease

OCGN : 0.7380 (+2.93%)
Ocugen to Host Conference Call on Wednesday, March 5, 2025 at 8:30 A.M. ET to Discuss Business Updates and Fourth Quarter and Full Year 2024 Financial Results

OCGN : 0.7380 (+2.93%)
Ocugen, Inc. Announces Dosing Completion in the Phase 2 ArMaDa Clinical Trial for OCU410—a Multifunctional Modifier Gene Therapy for the Treatment of Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

OCGN : 0.7380 (+2.93%)
INDUS Files Preliminary Proxy Statement

INDUS Realty Trust, Inc. (Nasdaq: INDT) (“INDUS” or the “Company”) , a U.S. based industrial/logistics REIT, announced that it has filed its preliminary proxy statement with the U.S. Securities...

INDT : 66.99 (+0.01%)
SHAREHOLDER ALERT: Weiss Law Reminds INFI, INDT, MLVF, and SHBI Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

INDT : 66.99 (+0.01%)
INFI : 0.0080 (-50.00%)
SHBI : 13.15 (+0.84%)
MLVF : 16.97 (+0.24%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INDT, PTRS, FOCS

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

PTRS : 7.15 (+0.99%)
INDT : 66.99 (+0.01%)
FOCS : 52.99 (-0.02%)
Moore Kuehn Encourages JNCE, USX, INDT, and BHWB Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

JNCE : 1.8800 (-2.59%)
INDT : 66.99 (+0.01%)
USX : 6.14 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USX, INDT, MLVF

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

INDT : 66.99 (+0.01%)
USX : 6.14 (unch)
MLVF : 16.97 (+0.24%)
SHAREHOLDER ALERT: Weiss Law Reminds INFI, INDT, SUMO, and MLVF Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

SUMO : 12.04 (-0.08%)
INDT : 66.99 (+0.01%)
INFI : 0.0080 (-50.00%)
MLVF : 16.97 (+0.24%)
INDUS Announces Quarterly Cash Dividend

INDUS Realty Trust, Inc. (Nasdaq: INDT) (“INDUS” or the “Company”) a U.S.-based industrial/logistics REIT, announced that its Board of Directors has declared a quarterly cash dividend on its common...

INDT : 66.99 (+0.01%)
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates TA, INDT, INFI, BRMK

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

BRMK : 4.82 (-2.63%)
INDT : 66.99 (+0.01%)
INFI : 0.0080 (-50.00%)
TA : 86.00 (-0.01%)
SHAREHOLDER ALERT: Weiss Law Reminds BRMK, FOCS, INFI, and INDT Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

BRMK : 4.82 (-2.63%)
INDT : 66.99 (+0.01%)
FOCS : 52.99 (-0.02%)
INFI : 0.0080 (-50.00%)
INVESTIGATION ALERT: Halper Sadeh LLC Investigates INDT, FOCS, JNCE, PTRS

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

PTRS : 7.15 (+0.99%)
JNCE : 1.8800 (-2.59%)
INDT : 66.99 (+0.01%)
FOCS : 52.99 (-0.02%)
INDUS Files Preliminary Proxy Statement

INDUS Realty Trust, Inc. (Nasdaq: INDT) (“INDUS” or the “Company”) , a U.S. based industrial/logistics REIT, announced that it has filed its preliminary proxy statement with the U.S. Securities...

INDT : 66.99 (+0.01%)
SHAREHOLDER ALERT: Weiss Law Reminds INFI, INDT, MLVF, and SHBI Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

INDT : 66.99 (+0.01%)
INFI : 0.0080 (-50.00%)
SHBI : 13.15 (+0.84%)
MLVF : 16.97 (+0.24%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INDT, PTRS, FOCS

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

PTRS : 7.15 (+0.99%)
INDT : 66.99 (+0.01%)
FOCS : 52.99 (-0.02%)
Moore Kuehn Encourages JNCE, USX, INDT, and BHWB Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

JNCE : 1.8800 (-2.59%)
INDT : 66.99 (+0.01%)
USX : 6.14 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USX, INDT, MLVF

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

INDT : 66.99 (+0.01%)
USX : 6.14 (unch)
MLVF : 16.97 (+0.24%)
SHAREHOLDER ALERT: Weiss Law Reminds INFI, INDT, SUMO, and MLVF Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

SUMO : 12.04 (-0.08%)
INDT : 66.99 (+0.01%)
INFI : 0.0080 (-50.00%)
MLVF : 16.97 (+0.24%)
INDUS Announces Quarterly Cash Dividend

INDUS Realty Trust, Inc. (Nasdaq: INDT) (“INDUS” or the “Company”) a U.S.-based industrial/logistics REIT, announced that its Board of Directors has declared a quarterly cash dividend on its common...

INDT : 66.99 (+0.01%)
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates TA, INDT, INFI, BRMK

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

BRMK : 4.82 (-2.63%)
INDT : 66.99 (+0.01%)
INFI : 0.0080 (-50.00%)
TA : 86.00 (-0.01%)
SHAREHOLDER ALERT: Weiss Law Reminds BRMK, FOCS, INFI, and INDT Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

BRMK : 4.82 (-2.63%)
INDT : 66.99 (+0.01%)
FOCS : 52.99 (-0.02%)
INFI : 0.0080 (-50.00%)
INVESTIGATION ALERT: Halper Sadeh LLC Investigates INDT, FOCS, JNCE, PTRS

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

PTRS : 7.15 (+0.99%)
JNCE : 1.8800 (-2.59%)
INDT : 66.99 (+0.01%)
FOCS : 52.99 (-0.02%)

Business Summary

Ocugen Inc. is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing therapies which address rare and underserved eye diseases. The company's product pipeline consists of OCU400, OCU300, OCU100 and OCU200 which are in clinical stage. Ocugen Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 0.7961
2nd Resistance Point 0.7730
1st Resistance Point 0.7450
Last Price 0.7380
1st Support Level 0.6939
2nd Support Level 0.6708
3rd Support Level 0.6428

See More

52-Week High 2.0600
Fibonacci 61.8% 1.4698
Fibonacci 50% 1.2875
Fibonacci 38.2% 1.1052
Last Price 0.7380
52-Week Low 0.5150

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.